Work

Mechanizmy działania leków immunomodulujących w szpiczaku plazmocytowym

Year: 2011
Type: article
Abstract: Hematologia 2011, tom 2, nr 2 www.hematologia.viamedica.plcostimulation and augments the NK cell cytotoxicity.It also shows to have anti-angiogenic properties.The latest studies have demonstrated that another immunomodulatory drugpomalidomide -has a potent anti-myeloma activity in vitro and in vivo, acting both directly on myeloma cells and on the cells in the bone marrow microenvironment.The aforementioned data of the literature suggest high efficacy of thalidomide, lenalidomide and pomalidomide in the treatment of myeloma.
Language: Polish
Subfield: Hematology
Field: Medicine
Open Access status: green
OpenAlex ID: W1906500643
FWCI: 0.178
Cites: 72
Cited by: 3
Related to: 9